Explainable Generative AI for Designing Functional Biomaterials Through All-Atom Protein Structure and Sequence Optimization

Abstract

Explainable generative artificial intelligence is becoming a foundational capability for designing functional biomaterials, particularly when protein structure and sequence must be optimized at all-atom resolution. This paper examines the system-level requirements for such platforms, treating them not as isolated prediction tools but as socio-technical infrastructures connecting atomistic modeling, generative sequence design, experimental validation, manufacturing, regulation, and global access. It analyzes how all-atom protein structure and sequence optimization supports biomaterials with catalytic, mechanical, adhesive, therapeutic, and environmental functions. The discussion emphasizes explainability as a layered property spanning atomic attributions, residue-level rationales, motif-level design intent, uncertainty quantification, provenance, and human interpretability. Architectural trade-offs are considered among generative fidelity, computational cost, synthesizability, robustness, and auditability. The paper also explores deployment pipelines that integrate high-performance computing, cloud services, robotic laboratories, and closed-loop design-build-test-learn cycles. Governance concerns include dual-use risk, biosecurity, reproducibility, fairness in benefit sharing, and policy mechanisms such as model documentation, datasheets, licensing, and export controls. Sustainability is treated as both a computational and experimental concern, because model training, simulation, and wet-lab screening impose material and energy costs. The conclusion argues that explainable generative protein design should be evaluated through functional, institutional, and ecological metrics rather than structural similarity alone. Such an orientation can help ensure that all-atom biomaterial design remains robust, accountable, and socially beneficial.